Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Canadian Journal of Urology
|
July 14, 2005
Web-based electronic health information systems for prostate cancer patients
Howard H Pai, Francis Lau
Brachytherapy
|
June 29, 2012
Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease
Howard H Pai, Mira Keyes, W James Morris, et al.
Journal of Applied Clinical Medical Physics
|
March 20, 2019
Maximizing rectal dose sparing with hydrogel: A retrospective planning study
Owen Paetkau, Isabelle M Gagne, Howard H Pai, et al.
The Journal of Urology
|
January 19, 2016
Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy
Nelson Leong, Howard H Pai, W James Morris, et al.
The Canadian Journal of Urology
|
September 6, 2007
What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?
Eric Berthelet, Tom Pickles, Pauline T Truong, et al.
International Journal of Cancer
|
June 26, 2009
Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen-dependent murine tumor model
Sara Hahn, Nancy J Nesslinger, Robert J Drapala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 26, 2023
BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer System
Krista Noonan, Jenny J Ko, Peter C Black, et al.
Oncoimmunology
|
August 13, 2014
Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy
Lisa Ds Johnson, Nancy J Nesslinger, Paul A Blood, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Canadian Journal of Urology
|
July 14, 2005
Web-based electronic health information systems for prostate cancer patients
Howard H Pai, Francis Lau
Brachytherapy
|
June 29, 2012
Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease
Howard H Pai, Mira Keyes, W James Morris, et al.
Journal of Applied Clinical Medical Physics
|
March 20, 2019
Maximizing rectal dose sparing with hydrogel: A retrospective planning study
Owen Paetkau, Isabelle M Gagne, Howard H Pai, et al.
The Journal of Urology
|
January 19, 2016
Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy
Nelson Leong, Howard H Pai, W James Morris, et al.
The Canadian Journal of Urology
|
September 6, 2007
What is the optimal duration of androgen deprivation therapy in prostate cancer patients presenting with prostate-specific antigen levels > 20 ng/ml?
Eric Berthelet, Tom Pickles, Pauline T Truong, et al.
International Journal of Cancer
|
June 26, 2009
Castration induces autoantibody and T cell responses that correlate with inferior outcomes in an androgen-dependent murine tumor model
Sara Hahn, Nancy J Nesslinger, Robert J Drapala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 26, 2023
BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer System
Krista Noonan, Jenny J Ko, Peter C Black, et al.
Oncoimmunology
|
August 13, 2014
Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy
Lisa Ds Johnson, Nancy J Nesslinger, Paul A Blood, et al.
Page
of 1